Amgen Reaches Settlement With Coherus in Trade Secrets Case Regarding Pegfilgrastim

Amgen and Coherus have settled the trade secret action brought by Amgen against Coherus that was pending in the Superior Court of California County of Ventura. The details of the settlement are confidential but Coherus will continue to market UDENYCA^®, its biosimilar to Neulasta^®, and will pay a mid-single digit royalty to Amgen.